Director's Dealing

RNS Number : 2527L

Accrol Group Holdings PLC

29 September 2016

 

This announcement contains inside information

Accrol Group Holdings plc (the "Company" or "Accrol")

Director's Dealing

Accrol Group Holdings plc, the AIM listed leading independent tissue converter, is pleased to announce that is has been notified that Stephen Crossley, CEO of Accrol, has purchased 100,000 ordinary shares of £0.001 each ("Ordinary Shares") via his SIPP on 29^th September 2016 at a price of 132p per Ordinary Share.

Following this transaction, Stephen has an interest in 100,000 Ordinary Shares, representing approximately 0.1 per cent. of the Company's issued Ordinary Share capital.

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Stephen Crossley
2	Reason for the notification
a)	Position/status	CEO
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Accrol Group Holdings plc
b)	LEI	(Pending)
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument Identification code	Ordinary shares of £0.001 ISIN: GB00BZ6VT592
b)	Nature of the transaction	Purchase of Ordinary Shares
c)	Price(s) and volume(s)	Price(s) Volume(s) 132p 100,000
d)	Aggregated information - Aggregated volume - Price	N/A - single transaction
e)	Date of the transaction	29th September 2016
f)	Place of the transaction	London Stock Exchange, AIM

For further information please contact:
Zeus Capital Limited (Nominated Adviser & Broker)
Dan Bate / Jonathan Sharp	Tel: [phone]
Dominic King / Adam Pollock / Mike Seabrook	Tel: [phone]
Camarco (Media enquiries)
Jennifer Renwick / Billy Clegg	Tel: [phone]

Notes to Editors

Accrol manufactures toilet rolls, kitchen rolls and facial tissues as well as other tissue products at the Company's 350,000 sq. ft. manufacturing, storage and distribution facility in Blackburn, Lancashire. Accrol currently manufactures approximately 16 million units per week and supplies some of the UK's largest retailers, providing both Accrol branded and Private Label products.

 

END

 

 

DSHBUGDCGXDBGLC